Skip to content
tifluadom

Structure via PubChem · Public domain (PubChem)

EntityQ7801294· pop 9· linked from 985 articles

Tifluadom is a benzodiazepine derivative with an unusual activity profile. Unlike most benzodiazepines, tifluadom has no activity at the GABAA receptor, but instead is a selective agonist for the κ-opioid receptor. It has potent analgesic and diuretic effects in animals, and also has sedative effects and stimulates appetite.

In the Vinony graph

Within Vinony's link graph, tifluadom is referenced by 985 other articles, and connects out to cannabinoids, OPRK1 and benzodiazepine drug.

It sits within the topics 2-Fluorophenyl compounds, Benzodiazepines and Carboxamides.

Its subject is documented across 8 Wikipedia language editions.

Chemical data

Formula
C22H20FN3OS
Molecular weight
393.5 g/mol
IUPAC name
N-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]thiophene-3-carboxamide
SMILES
CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C4=CSC=C4
InChIKey
NPGABYHTDVGGJK-UHFFFAOYSA-N
XLogP
4
Polar surface area
72.9 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule

via ChEMBL · EBI

Wikidata facts

Mass
393.131
Show 4 more facts
chemical formula
C₂₂H₂₀FN₃OS
Commons category
Tifluadom
canonical SMILES
CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C4=CSC=C4
subject has role
diuretic
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

Tifluadom is a benzodiazepine derivative with an unusual activity profile. Unlike most benzodiazepines, tifluadom has no activity at the GABAA receptor, but instead is a selective agonist for the κ-opioid receptor. It has potent analgesic and diuretic effects in animals, and also has sedative effects and stimulates appetite.

While tifluadom has several effects which might have potential uses in medicine, such as analgesia and appetite stimulation, κ-opioid agonists tend to produce undesirable effects in humans such as dysphoria and hallucinations, and so these drugs tend to only be used in scientific research. Dysphoric effects are similar to those seen when using other κ-opioid receptor agonists like pentazocine and salvinorin A, and can be considered the opposite of morphine-induced euphoria. As such, kappa agonists are believed to have very limited abuse potential.

Excerpted from Wikipedia’s “tifluadom” article, available under the CC BY-SA 4.0 licence.

Available in 8 languages

via Wikidata sitelinks · CC0

Connections

Categories